Surgical Drapes Market By Type (Reusable, Disposable), By Risk Type (Moderate (AAMI Level 3), High (AAMI Level 4), Others), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
세계 수술용 드레이프 시장은 2022년 15억 달러로 평가되며 2023년부터 2032년까지 연평균 3.6% 성장하여 2032년에는 21억 달러에 달할 것으로 예상됩니다.
수술용 드레이프는 의료 및 수술 현장에서 수술 중 무균 상태를 유지하기 위해 사용되는 무균 보호 장벽입니다. 이 드레이프는 일반적으로 폴리프로필렌, 면, 폴리에스테르와 같은 직물 또는 부직포로 만들어지며, 환자의 피부와 수술 팀 사이의 미생물 이동을 방지할 뿐만 아니라 수술 부위 주변에 깨끗하고 통제된 환경을 조성하도록 설계되어 있습니다. 수술용 드레이프는 다양한 수술에 맞게 다양한 모양과 크기로 제공되며, 필요한 부분만 노출되고 나머지는 덮여 있는 상태로 유지되도록 설계되어 있습니다. 드레이프에는 접착제와 울타리가 있어 치료가 필요한 특정 부위에 접근할 수 있습니다. 이러한 드레이프는 수술 부위의 오염 위험을 최소화하고 체액 유출을 방지하고 무균 상태를 유지하여 수술 부위의 감염을 예방하는 데 필수적입니다.
수술 건수의 증가와 병원 내 감염(HAI)의 급증은 수술용 드레이프 시장의 주요 촉진요인으로, HAI는 입원 환자의 이환율과 사망률의 주요 원인이 되고 있습니다. 예를 들어, 세계보건기구(WHO) 보고서(2021)에 따르면, 중환자실 환자의 최대 30%가 적어도 한 가지 이상의 병원 내 감염(HAI)의 영향을 받고 있습니다. 이러한 심각한 확산은 의료 현장에서 무균 환경을 조성하고 유지하기 위해 수술용 드레이프 사용을 포함한 엄격한 감염 관리 조치의 필요성을 강조하고 있습니다.
또한, 비정부 및 정부 기관은 환자와 의료 시설을 교육하는 프로그램과 캠페인을 실시하여 감염 관리 조치에 대한 인식을 높이기 위한 이니셔티브를 주도하고 있습니다. 이러한 인식의 증가는 수술용 드레이프 사용을 권장하는 감염 예방 및 관리 지침의 채택이 급증하는 것과 함께 시장 성장을 더욱 촉진할 것으로 예상됩니다. 이러한 요인들은 수술용 드레이프가 감염 위험을 줄이고 환자의 안전을 향상시키는 데 있어 매우 중요한 역할을 하고 있음을 강조하고 있습니다.
또한, 수술용 드레이프 시장은 환경적 지속가능성에 대한 관심이 높아지는 추세에 힘입어 성장세를 보이고 있습니다. 플라스틱 드레이프가 환경에 미치는 영향을 줄이기 위한 노력은 성장의 중요한 원동력이 되고 있습니다. 정부 기관, 업계 리더, 의료 시설 등 다양한 이해관계자들이 지속가능성을 위한 노력을 적극적으로 지지하고 있습니다. 여기에는 드레이프 제조에 친환경 소재의 사용을 촉진하고 책임감 있는 폐기 방법을 장려하는 것이 포함되며, 이는 의료를 보다 친환경적이고 환경 친화적으로 만들기 위한 전 세계의 노력과 일치합니다. 예를 들어, Molnlycke Health Care와 같은 회사는 BARRIER Universal ISCC와 같은 제조 공정을 강화하여 화석에서 발생하는 CO2 배출을 줄이고 전체 공급망의 지속가능성을 촉진하기 위해 적극적인 조치를 취하고 있습니다. 이러한 추세는 환경 친화적인 건강 관리 솔루션을 향한 전 세계의 광범위한 움직임과 일치하며 시장 성장을 주도하고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 개요
- 시장 정의와 범위
- 주요 조사 결과
- Porter's Five Forces 분석
- 시장 역학
- 성장 촉진요인
- 수술 건수 급증
- 수술용 드레이프의 기술적 진보
- 감염 예방과 감염 제어를 위한 정부 정책 성장
- 성장 억제요인
- 기회
제4장 수술용 드레이프 시장 : 유형별
제5장 수술용 드레이프 시장 : 위험 유형별
- 개요
- 중등도(AAMI 레벨 3)
- 고도(AAMI 레벨 4)
- 기타
제6장 수술용 드레이프 시장 : 최종사용자별
제7장 수술용 드레이프 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카, 중동 및 아프리카
제8장 경쟁 상황
- 서론
- 주요 성공 전략
- 주요 10개사의 제품 매핑
- 경쟁 대시보드
- 경쟁 히트맵
- 주요 기업의 포지셔닝, 2022년
제9장 기업 개요
- Molnlycke Health Care AB
- Paul Hartmann AG
- Narang Medical Limited
- Standard Textile Co., Inc.
- Delta Med SpA
- Medline Industries Inc.
- Priontex
- Medica Europe BV
- Cardinal Health
- 3M Company
ksm
The global surgical drapes market was valued at $1.5 billion in 2022, and is projected to reach $2.1 billion by 2032, growing at a CAGR of 3.6% from 2023 to 2032. Surgical drapes are sterile and protective barriers used in medical and surgical settings to maintain aseptic conditions during procedures. These drapes are typically made from woven and non-woven materials, such as polypropylene, cotton and polyester, and are designed to prevent the transfer of microorganisms between the patient's skin and the surgical team, as well as to create a clean, controlled environment around the surgical site. Surgical drapes are available in various shapes and sizes to accommodate different procedures, ensuring that only the necessary area is exposed while the rest remains covered. They feature adhesive or fenestrations to provide access to the specific area requiring treatment. These drapes are essential in preventing surgical site infections by minimizing the risk of contamination, controlling fluid runoff, and maintaining a sterile field, which is crucial for successful surgical outcomes and patient safety.
The increase in number of surgeries and surge in hospital-acquired infections (HAIs) are major drivers of the surgical drapes market. HAIs are the leading cause of morbidity and mortality in hospitalized patients. For instance, the report of World Health Organization (WHO) 2021, stated that, up to 30% of patients are affected by at least one hospital acquired infections (HAIs) in intensive care units. This alarming prevalence underscores the need for stringent infection control measures, including the use of surgical drapes, to create and maintain sterile environments in healthcare settings.
Moreover, both non-governmental and government organizations are spearheading initiatives aimed at increasing awareness of infection control measures by conduct programs and campaigns to educate patients and healthcare facilities. Thus, increased awareness, combined with the surge in adoption of infection prevention and control guidelines that recommend the use of surgical drapes, is anticipated to further fuel the market growth. These factors collectively highlight the pivotal role of surgical drapes in mitigating infection risks and enhancing patient safety.
Moreover, the market for surgical drapes is benefiting from a growing emphasis on environmental sustainability. The move towards reducing the environmental impact of plastic drapes is a significant driver propelling the growth. Various stakeholders, including government organizations, industry leaders, and healthcare facilities, are actively endorsing sustainability initiatives. This involves promoting the use of eco-friendly materials in drape manufacturing and encouraging responsible disposal practices, aligning with global efforts to make healthcare more environmentally conscious and eco-friendly. For instance, companies like Molnlycke Health Care are taking proactive steps, enhancing manufacturing processes, such as BARRIER Universal ISCC, to reduce fossil-based CO2 emissions and promote sustainability throughout the supply chain. This trend aligns with the broader global movement towards environmentally conscious healthcare solutions and thus drive the market growth.
In addition, the key players are adopting strategic initiatives to foster growth, including expansion and product launches. For instance, in March 2022, Cardinal Health, a global manufacturer and distributor of medical and laboratory products announced the launch of the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate (CHG). Such innovative product launches and expansions are expected to be propelling market growth, as they address the evolving needs of healthcare professionals and enhance infection control measures, ultimately contributing to improved patient outcomes.
The surgical drapes market is segmented into type, risk type, end user and region. On the basis of type, the market is categorized into reusable and disposable. On the basis of risk type, the market is categorized into moderate (AAMI Level 3), high (AAMI Level 4) and others. On the basis of end user, the market is segregated into hospitals, ambulatory surgical centers and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global surgical drapes market include Molnlycke Health Care AB, Narang Medical Limited, Cardinal Health, Medline Industries Inc, Medica Europe BV, Priontex, Delta Med SpA Paul Hartmann AG, 3M Company and Standard Textile Co., Inc. The key players have adapted product launch as the strategies to enhance its product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical drapes market analysis from 2022 to 2032 to identify the prevailing surgical drapes market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the surgical drapes market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global surgical drapes market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Technology Trend Analysis
- Patient/epidemiology data at country, region, global level
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Type
By Risk Type
- Others
- Moderate (AAMI Level 3)
- High (AAMI Level 4)
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA
Key Market Players:
- Narang Medical Limited
- Delta Med SpA
- Cardinal Health
- Molnlycke Health Care AB
- Priontex
- Paul Hartmann AG
- 3M Company
- Medica Europe BV
- Standard Textile Co., Inc.
- Medline Industries Inc.
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. High bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Surge in number of surgeries
- 3.4.1.2. Technological advancements in surgical drapes
- 3.4.1.3. Growth in government initiatives for infection prevention and control
- 3.4.2. Restraints
- 3.4.2.1. Competition among the key players
- 3.4.2.2. Product recalls
- 3.4.3. Opportunities
- 3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: SURGICAL DRAPES MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Reusable
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Disposable
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
CHAPTER 5: SURGICAL DRAPES MARKET, BY RISK TYPE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Moderate (AAMI Level 3)
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. High (AAMI Level 4)
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
CHAPTER 6: SURGICAL DRAPES MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
CHAPTER 7: SURGICAL DRAPES MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Risk Type
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Market size and forecast, by Type
- 7.2.5.1.2. Market size and forecast, by Risk Type
- 7.2.5.1.3. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Market size and forecast, by Type
- 7.2.5.2.2. Market size and forecast, by Risk Type
- 7.2.5.2.3. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Market size and forecast, by Type
- 7.2.5.3.2. Market size and forecast, by Risk Type
- 7.2.5.3.3. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Risk Type
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Market size and forecast, by Type
- 7.3.5.1.2. Market size and forecast, by Risk Type
- 7.3.5.1.3. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Market size and forecast, by Type
- 7.3.5.2.2. Market size and forecast, by Risk Type
- 7.3.5.2.3. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Market size and forecast, by Type
- 7.3.5.3.2. Market size and forecast, by Risk Type
- 7.3.5.3.3. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Market size and forecast, by Type
- 7.3.5.4.2. Market size and forecast, by Risk Type
- 7.3.5.4.3. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Market size and forecast, by Type
- 7.3.5.5.2. Market size and forecast, by Risk Type
- 7.3.5.5.3. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Market size and forecast, by Type
- 7.3.5.6.2. Market size and forecast, by Risk Type
- 7.3.5.6.3. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Risk Type
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Market size and forecast, by Type
- 7.4.5.1.2. Market size and forecast, by Risk Type
- 7.4.5.1.3. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Market size and forecast, by Type
- 7.4.5.2.2. Market size and forecast, by Risk Type
- 7.4.5.2.3. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Market size and forecast, by Type
- 7.4.5.3.2. Market size and forecast, by Risk Type
- 7.4.5.3.3. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Market size and forecast, by Type
- 7.4.5.4.2. Market size and forecast, by Risk Type
- 7.4.5.4.3. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Market size and forecast, by Type
- 7.4.5.5.2. Market size and forecast, by Risk Type
- 7.4.5.5.3. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Market size and forecast, by Type
- 7.4.5.6.2. Market size and forecast, by Risk Type
- 7.4.5.6.3. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Risk Type
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Market size and forecast, by Type
- 7.5.5.1.2. Market size and forecast, by Risk Type
- 7.5.5.1.3. Market size and forecast, by End User
- 7.5.5.2. South Africa,
- 7.5.5.2.1. Market size and forecast, by Type
- 7.5.5.2.2. Market size and forecast, by Risk Type
- 7.5.5.2.3. Market size and forecast, by End User
- 7.5.5.3. Saudi Arabia
- 7.5.5.3.1. Market size and forecast, by Type
- 7.5.5.3.2. Market size and forecast, by Risk Type
- 7.5.5.3.3. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Market size and forecast, by Type
- 7.5.5.4.2. Market size and forecast, by Risk Type
- 7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product mapping of top 10 player
- 8.4. Competitive dashboard
- 8.5. Competitive heatmap
- 8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
- 9.1. Molnlycke Health Care AB
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.2. Paul Hartmann AG
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.3. Narang Medical Limited
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.4. Standard Textile Co., Inc.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.5. Delta Med SpA
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.6. Medline Industries Inc.
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.7. Priontex
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.8. Medica Europe BV
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.9. Cardinal Health
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
- 9.10. 3M Company
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
